3 Biotech Firms Kick Off '22 With IPOs Totaling $482M
Three Massachusetts biotechnology companies, led by Cooley LLP-advised CinCor Pharma, began trading Friday after pricing initial public offerings totaling $482 million, marking the year's first three IPOs from the industry....To view the full article, register now.
Already a subscriber? Click here to view full article